Skip to main content
. 2024 May 24;32(2):200818. doi: 10.1016/j.omton.2024.200818

Figure 4.

Figure 4

CDKN2A copy-number status screening in BlCa patients

(A) Comparison of CDKN2A copy number status between DNA-seq and qPCR in PDX models (left) and NCI-60/UBC-40 cell line panels and qPCR in 10 selected cell lines (right). (B) REMARK diagram of the study. (C) Distribution of CDKN2A copy number status in tumors of our BlCa screening cohort.